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Abstract 
Oncogene-induced senescence (OIS) is a tumour suppressive response to oncogene activation 
that can be transmitted to neighbouring cells through secreted factors of the senescence-
associated secretory phenotype (SASP). Currently, primary and secondary senescent cells are 
not considered functionally distinct endpoints. Using single-cell analysis we observed two distinct 
transcriptional endpoints, a primary marked by Ras and a secondary marked by Notch activation. 
We find that secondary oncogene-induced senescence in vitro and in vivo requires Notch, rather 
than SASP alone as previously thought. Moreover, Notch signalling weakens, but does not 
abolish, SASP in secondary senescence. Global transcriptomic differences, a blunted SASP 
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response and the induction of fibrillar collagens in secondary senescence point towards a 
functional diversification between secondary and primary senescence. 
 
Introduction  
Cellular senescence is a stress response, resulting in stable cell cycle arrest, tumour suppression, 
ageing and wound healing (Adams, 2009; Campisi, 2013; Jun and Lau, 2010; van Deursen, 
2014). Aberrant activation of the Ras oncogene triggers oncogene-induced senescence (OIS), 
conferring a precancerous state (Di Micco et al., 2006; Serrano et al., 1997). OIS is an in vivo 
tumour suppressor mechanism (Braig et al., 2005; Xue et al., 2007) with the p53 and Rb/p16 
pathways as major mediators of senescence induction and maintenance (Kirschner et al., 2015; 
Serrano et al., 1997). OIS is characterised by multiple phenotypical changes, such as 
heterochromatic foci (Adams, 2007; Chandra and Kirschner, 2016; Criscione et al., 2016; 
Kirschner et al., 2015; Narita et al., 2003) and the senescence-associated secretory phenotype 
(SASP) (Acosta et al., 2008; Coppe et al., 2008; Kuilman et al., 2008). Through the secretion of 
extracellular matrix proteases, interleukins and chemokines, OIS cells recruit immune cells, 
mediating their own clearance. SASP has been implicated in cancer initiation (Watanabe et al., 
2017) by creating an inflammatory pro-tumorigenic microenvironment. SASP factors play a role 
in cellular reprogramming (Mosteiro et al., 2016; Ritschka et al., 2017) and contribute to ageing 
and tissue degeneration (Osorio et al., 2012; Soria-Valles et al., 2015). SASP acts in a paracrine 
fashion to induce secondary senescence in surrounding cells (Acosta et al., 2013). Paracrine 
secondary senescence is thought to enhance immune surveillance and to act as a failsafe 
mechanism minimising chances of retaining damaged cells (Acosta et al., 2013; Kuilman et al., 
2008; Nelson et al., 2012). Recently, ectopic Notch pathway activation has been implicated as an 
intermediate phenomenon during primary senescence induction, resulting in a distinct secretome 
(Hoare et al., 2016). The role of Notch in secondary OIS mediation remains undescribed. 
Here we use single-cell RNA-sequencing (scRNA-seq) to decipher the heterogeneity within OIS 
populations. Our single cell experiments reveal two distinct transcriptional end-points in primary 
senescence, separated by their activation of Notch, with secondary senescent cells uniformly 
progressing to an end-point characterised by Notch activation in vivo and in vitro. We confirm 
Notch mediated senescence as an essential mediator of secondary, juxtacrine senescence in 
OIS.  
Primary and secondary senescence have distinct transcriptomes 
To investigate dynamic changes and cell-cell heterogeneity in OIS, we performed a scRNA-seq 
time course experiment before and after 2, 4 and 7 days of RasV12 induction, using H-RasG12V-
induced IMR90 (ER:IMR90) fibroblasts (Young et al., 2009) and  Smart-Seq2 protocol (Picelli et 
al., 2014) (Fig.1a).  After stringent filtering (Fig.1b, Fig.S.1a-d, Table S1), we obtained a final cell 
count of 100/288 for day 0, 41/96 for day 2, 42/96 for day 4 and 41/288 for day 7 for downstream 
analysis (Fig.S.1d). To confirm a senescence phenotype at day 7, we profiled Bromodeoxyuridine 
(BrdU) incorporation (37/390 cells (9%)), SAHF (265/390 cells (68%)) and senescence associated 
beta-galactosidase (SA-Beta Gal) (428/523 cells (82%)) (Fig.S.1e). To assess time-dependent 
changes in the transcriptome, we ordered cells along a pseudo-temporal trajectory based on 
differential gene expression between growing and senescence (adjusted p<0.05,Table S.2 
(Fig.1c) (Kharchenko et al., 2014). Using Monocle2 (Qiu et al., 2017) we found a continuous 
progression from growing to senescence, with days 2 and 4 cells as intermediates and two distinct 
senescent populations (Fig.1c), suggesting two facultative, alternative endpoints. To determine 
whether RasV12 activation led to the split into two senescence populations (Fig.1c), we overlaid 
RasV12 expression onto the monocle plot (Fig.1b,c,Fig.S.1f,g,Table S.3). RasV12 expressing 
cells (Fig.1c, Ras+, round symbols) progressed to both senescence endpoints with a 21:4 skew 
towards the cluster designated OIS. Fibroblasts without detectable RasV12 expression uniformly 
progressed to the cluster tentatively designated secondary senescence, suggesting it as the 
obligate endpoint (cross symbols =Ras-, Fig.1c, Fisher’s exact test=1.64x10-6). Our inability to 
detect RasV12 in a subset of senescent cells suggests that senescence was induced as a 
secondary event. We verified HRAS as one of the top predicted upstream regulators for the 
senescence top population (p=3.1x10-34) using Ingenuity pathway analysis (IPA, 
Qiagen,Fig.S.1h). We confirmed a senescence phenotype for both populations by upregulation 
of key senescence genes (Fig.1d) cyclin-dependent kinase 1a (CDKN1A), cyclin-dependent 
kinase inhibitor 2b (CDKN2B) and SASP factors interleukin 8 (IL8), interleukin 6 (IL6) and 
interleukin 1B (IL1B) (p<0.05 for all genes, Fig.1d). To verify two major senescence populations 
transcriptome-wide, we used a consensus clustering approach, SC3 (Kiselev et al., 2017), with 
the number of clusters determined by silhouette plot (Rousseeuw, 1987) (Fig.S.1i). SC3 detected 
two senescence clusters largely overlapping with the subpopulations obtained by Monocle2 
(Cluster 1 16/21 or 76%  RasV12+ cells, Cluster 4 11/15 or 73% RasV12- cells), supporting the 
notion that the split into two senescence populations is based on the absence/presence of 
RasV12 (Fig.1e). To verify that populations observed are due to primary OIS and secondary 
senescence, we co-cultured ER:IMR90 with IMR90:GFP fibroblasts (10:1), where secondary 
senescence is induced in IMR90:GFP positive cells (Acosta et al., 2013). We generated scRNA-
seq data before and 7 days after RasV12 activation, using the 10x Genomics Chromium (Fig.1f). 
Senescence was confirmed on sorted populations by qPCR (Fig.S.1j) and SA-Beta gal staining 
for primary and secondary senescent cells (Fig.S.1k). Cells were annotated based on GFP, 
RasV12 expression and the G>T mutation of Ras gene (Fig.1g). We identified three distinct 
clusters using Seurat and Sparcl (Butler et al., 2018; Witten and Tibshirani, 2010), namely growing 
(blue dots), secondary senescence (GFP positive, black dots) and OIS (RasV12 positive, red 
dots), with significant enrichment for the OIS and secondary senescence populations (Chi-
squared test,p=4.1x10-14,Fig.1h). The secondary senescence cluster also contained a minor 
population of RasV12 expressing cells. This mirrors our earlier findings, confirming two facultative 
senescence endpoints for primary RasV12 senescent cells with GFP positive secondary 
senescent cells showing a uniform distribution. Senescence genes were upregulated in both 
senescent clusters, including CDKN1A, CDKN2B and IL8 (Fig.1i, Table S2) and long-term stable 
cell cycle arrest confirmed at 21 days post co-culture (Fig.S.1l). When overlaying transcriptomes 
of the time course and the co-culture experiments, a significant number of cells identified as OIS 
and secondary senescence (GFP and part of RasV12) clustered together (Fig.1j, Chi-squared 
test, p<0.05). The co-clustering by senescent signatures was achieved despite the data being 
generated by 10x or Smart-seq2. In summary, we identified two major transcriptional endpoints 
in primary OIS, whereas secondary senescent cells were uniformly assigned. 
Paracrine senescence is thought to be the main effector mechanism for secondary, cell extrinsic 
senescence induction (Acosta et al., 2013; Kuilman et al., 2008). To test if the secondary 
senescence cluster is explained by a paracrine signature, we overlaid bulk RNA-Seq data (Acosta 
et al., 2013). While we found a significant overlap with paracrine genes (Hypergeometric test: 
Paracrine/OIS and time-course secondary senescence/OIS (Ras-/Ras+) p<0.001; Paracrine/OIS 
and 10x secondary senescence/OIS p<0.001, 10x secondary senescence/OIS and time-course 
secondary senescence/OIS (Ras-/Ras+) p<0.001, Fig.1k,Table S.4), a large fraction of genes 
shared between our two single cell experiments remained unexplained, suggesting the 
involvement of additional pathways in secondary senescence. 
  
The transcriptome of secondary and a subset of primary senescent cells is characterised 
by Notch 
Since the secondary senescence clusters were only partially characterised by a paracrine 
senescence signature, we explored consistent differences between the secondary senescence 
and the primary OIS clusters. We assessed the most differentially expressed genes and detected 
fibrillar collagens (Collagen 1A1, 3A1 and 5A2, Fig.2a). Downregulation of fibrillar collagens is 
consistently observed in senescence (Hoare et al., 2016), but they failed to downregulate in the 
secondary senescence cluster (Table S.2, Fig.2a). A similar failure to downregulate collagens 
was reported in a specialised primary senescence phenotype, induced by ectopic, temporal 
activation of Notch (Hoare et al., 2016). The same report suggested that the secretome in 
RasV12-induced senescence was regulated by CCAAT/enhancer-binding protein beta (CEBPB), 
with Notch-induced senescence relying on transforming growth factor beta (TGFB) (Fig.2b) 
(Hoare et al., 2016). Several lines of evidence identify a NIS signature in the secondary 
senescence cluster. Firstly, IPA pathway analysis identifies TGFB1 as exclusively activated in the 
secondary senescence clusters compared to growing or the primary OIS (Fig.2c). In contrast, 
RELA and IL1B pathways, regulators of the CEBPB transcriptome, were differentially activated in 
primary OIS clusters (Fig.2c). Consistent with our RasV12 annotation, HRAS was exclusively 
activated in primary OIS (Fig.2c, Supp. Fig.2a). Secondly, we profiled candidate genes involved 
in Notch signalling and TGFB activation. When plotting TGFB induced transcript 1, (TGFB1I1) 
with Notch-target connective tissue growth factor (CTGF) and CEBPB, we identified a significant 
(p<0.05) upregulation of CTGF and TGFB1I1 genes in the secondary senescence cluster with a 
simultaneous downregulation of CEBPB, significant on the protein, but not mRNA level (Fig.2d, 
e, p=0.016), resembling the TGFB/CEBPB bias in NIS. This bias was confirmed by qPCR (Fig.2d, 
TGFB1 p=0.02, TGFBI p=0.05). 
Thirdly, we applied an unbiased genome-wide analysis. We calculated the enrichment of NIS and 
Ras-induced senescence (RIS) signatures in the primary OIS and secondary senescence 
transcriptomes using gene set enrichment analysis (GSEA)(Subramanian et al., 2005) on ranked 
transcriptome differences between NIS and RIS (Fig.2f). Secondary senescence signatures from 
the time course and co-culture experiments were highly enriched in NIS (NES=2.61, FDR<0.005 
for time course, NES=2.89, FDR<0.005 Fig. 2f). Primary OIS transcriptomes showed an 
enrichment for RIS (Fig.S.2b). Finally, we interrogated the extent of NIS in secondary senescence 
by comparing the most differentially regulated genes (adjusted p<0.05) between RIS and NIS. 
We found a significant enrichment of NIS genes in our secondary senescence transcriptome in 
the time course and co-culture experiments with primary OIS signature being enriched for RIS 
(Fig.2f,g, Fig.S.2b,c). In summary, our data identify a pronounced NIS signature in secondary 
senescence and in a subset of primary senescent cells as an alternative endpoint to OIS. 
NIS is a secondary senescence effector mechanism during OIS 
  
We next established Notch signalling as an effector mechanism in secondary senescence. We 
generated IMR90 fibroblasts with compromised Notch signalling by introducing a dominant 
negative form of mastermind-like protein 1 fused to mVenus (mVenus:dnMAML1) or empty vector 
(mVenus:EV) control and co-cultured with ER:Ras IMR90 cells in the presence of tamoxifen 
(Fig.3a). At day 7 co-culture, mVenus:dnMAML1 compared to mVenus:EV cells exhibited lower 
expression of extracellular matrix gene COL3A1 (p=0.02) and Notch target CTGF (p=0.056, 
Fig.S.3a) as measured by qPCR, confirming impaired Notch signalling. Several lines of evidence 
show causal involvement of Notch signalling in secondary senescence. Firstly, we scored 
mVenus (YFP) signal between mVenus:dnMAML1 and mVenus:EV cells at day 0 (Growing) and 
day 7 co-culture with ER:Ras. At day 7, we observed significantly more mVenus:dnMAML1 
compared to mVenus:EV cells (p=0.01), suggesting that primary OIS cells have less secondary 
senescence effect on neighbouring cells when harbouring perturbed Notch signalling (Fig.S.3b). 
No significant difference in mVenus positive cells was observed in growing mVenus:EV compared 
to mVenus:dnMAML1 cells (p=0.38), showing that the dnMAML1 itself does not affect cell 
numbers (Fig.S.3b). Secondly, we scored EdU incorporation between mVenus:dnMAML1 and 
mVenus:EV cells at days 0 and 7 (Fig.3b). At day 7, we observed significantly more EdU 
incorporation in mVenus:dnMAML1 compared to mVenus:EV cells (p=0.01), with day 7 
mVenus:dnMAML1 cells showing similarly high levels of EdU incorporation as growing 
mVenus:dnMAML1 and growing mVenus negative ER:Ras conditions (p=0.997 and p=0.08), 
suggesting that the induction of secondary senescence was abolished due to Notch perturbation 
(Fig.3b). As expected, ER:Ras cells showed low levels of EdU incorporation at day 7 tamoxifen 
(p=0.01 for ER:Ras/mVenus:dnMAML1 co-culture and p=0.0005 for ER:Ras/mVenus:EV co-
culture, Fig.3b). 
Thirdly, we investigated SAHF in primary OIS and secondary senescence. Pimary OIS cells 
displayed SAHF as expected (p=4.437x10-6, Fig.S.3c). Secondary senescent cells (mVenus:EV) 
did not show significant SAHF formation when compared to OIS (p=0.32, Fig.S.3c). This is 
consistent with published data where impaired Notch signalling partially suppresses SAHF 
formation in primary senescence (Parry et al., 2018). In summary, we show that Notch signalling 
mediates secondary senescence in vitro. 
To establish transcriptional differences between secondary senescence with and without Notch 
signalling, we generated scRNA-seq data from IMR90 mVenus:EV and mVenus:dnMAML1 co-
cultures with ER:Ras IMR90 at day 7 tamoxifen. To integrate this data set with our previous 
secondary senescence transcriptomes (Fig.1h), we projected the mVenus:EV and 
mVenus:dnMAML1 using Scmap (Kiselev et al., 2018). Scmap clearly matches all primary 
senescent cells containing RasV12 to the OIS population (Fig.3c) and identifies significantly more 
secondary senescence cells in mVenus:EV compared to mVenus:dnMaml1 (Fig.3c, 37% vs 24%, 
Chi-squared test, p=0.00062), confirming a role of Notch in secondary senescence. To explore 
transcriptomic differences between secondary senescence, we plotted all cells using Seurat, 
which separated mVenus:EV and mVenus:dnMAML1 into distinct secondary senescence clusters 
(Fig.3d). We confirmed differences in the activation of Notch pathway between mVenus:EV and 
mVenus:dnMaml1 by GSEA analysis (Fig.3e, NES=-1.35) and on the gene level for fibrillar 
collagens (Fig.3f, p<0.05). Notch signalling blunts the cytokine response in senescence as SASP 
factors (Fig.3g,NES=1.1) and the interferon-gamma response (Fig.S.3d, NES=1.48) are 
differentially regulated between mVenus:EV and mVenus:dnMaml1 as judged by GSEA. 
Importantly, E2F targets, whose downregulation is one of the hallmarks of senescence, are 
upregulated in mVenus:dnMaml1 cells compared to mVenus:EV (Fig.3h, p=n.s.) (Narita et al., 
2003), which offers an explanation for the strong phenotype differences we observed between 
the two conditions (see Fig.3b). 
Notch induces senescence in a juxtacrine manner through cell-to-cell contact. We performed 
transwell experiments to verify the effect of cell-to-cell contact on the secondary senescence 
transcriptome. We co-cultured ER:Ras cells with GFP cells (GFP contact, Fig. 3i) and GFP cells 
on their own in the transwell of the same well (GFP no contact). In this setting, GFP no contact 
cells shared media with ER:Ras cells, where cytokines can be transferred, but no cell-to-cell 
contact is possible. We performed bulk RNA-sequencing of GFP contact and no contact cells 7 
days after tamoxifen induction and confirmed enhanced expression of previously observed 
marker genes for NIS secondary senescence in GFP contact cells (Fig.3j). In addition, GSEA 
confirmed enrichment of Notch (NES=1.59, FDR q=0.019) and TGF beta (NES=1.87, FDR 
q=0.0016) signalling (Fig.3k and Fig.S.3e) in GFP contact cells. Pathway analysis confirmed 
significant upregulation of previously described senescence pathways such as “Senescence and 
Autophagy in Cancer” and “Matrix Metalloproteases” in GFP contact compared to GFP no contact 
cells (Fig.3l). Equally, GSEA showed repression of E2F target genes in GFP contact compared 
to GFP no contact fibroblasts (Fig.3m) except for E2F7, which is known to be upregulated in 
senescence (Fig.3j) (Aksoy et al., 2012). GSEA analysis suggests that the global differences 
between GFP contact and no contact cells resemble the differences between mVenus:EV and 
mVenus:dnMaml1 secondary senescence (Fig.S.3f). 
OIS induction is a multi-step process with an early proliferative phase at days 1-3, followed by a 
phenotype transition phase at days 3-5, and established senescence from day 7 after RasV12 
expression (Young et al., 2009). To compare the impact of the different phases of primary OIS 
onto secondary senescence, we co-cultured mVenus:EV or mVenus:dnMAML1 cells repeatedly 
with ER:Ras cells at days 3-6 or at days 7-10 after RasV12 induction (Fig.S.3g). As expected, 
ER:Ras cells showed low levels of EdU incorporation in mVenus:dnMAML1 (Day 3, Day 7 
p<0.001) or mVenus:EV co-culture (Day 3, Day 7 p<0.001)  (Fig.S.3h,i) as a result of primary 
OIS. Co-culturing mVenus:EV with ER:Ras cells in the phenotype transition phase (days 3-5 after 
RasV12 induction), lead to a significant reduction in EdU when compared to uninduced co-
cultures (p<0.001,Fig.S.3h), suggesting that secondary senescence was induced by transition 
phase primary OIS cells. The transition phase effect is Notch-dependent since it cannot be 
induced in mVenus:dnMAML1 cells (p=0.12, Fig.S.3i). In contrast, by co-culturing mVenus:EV 
cells with primary OIS cells in established senescence phase (7-10 after RasV12 induction), we 
were unable to detect a reduction in EdU incorporation in mVenus:EV cells compared to 
uninduced co-cultures (p=0.59,Fig.S.3h), mirroring results obtained in mVenus:dnMAML1 co-
cultures (p=0.99,Fig.S.3i). From day 4 co-culture, we detected a significant upregulation of Notch1 
on the cell surface of mVenus:EV (p= 0.041 day 4, p=0.038 day 7, data not shown) and 
mVenus:dnMaml1 (p=0.023 day 4, p=0.046 day 7, data not shown) cells compared to growing, 
providing a pathway to NIS induction (Fig.S.3j). These results highlight a need for ER:Ras 
fibroblasts to be in phenotype transition phase to mediate secondary senescence via Notch1. 
Overall, our data identify Notch as a key mediator of secondary senescence.  
Secondary senescent hepatocytes are characterised by NIS signature 
To test the involvement of NIS in vivo, we utilised a model where primary senescence is induced 
in a subpopulation of hepatocytes following Mdm2 deletion (Bird et al., 2018). This model is 
activated by hepatocyte-targeted recombination of Mdm2 (βNF induction AhCre, Mdm2-), 
resulting in primary senescence in Mdm2- cells. Mdm2- hepatocytes induce secondary 
senescence in neighbouring hepatocytes (Bird et al., 2018) (Fig.4a). In this model, the presence 
of p53 induction through Mdm2 deletion with medium levels of CDKN1A (non-senescence/primary 
p<0.001) marks primary senescence induction (Bird et al., 2018) (Fig.4b,Fig.S.4a,b). 
Physiological levels of P53 and high levels of CDKN1A (CDKN1A expression secondary/primary 
p<0.0001) marks secondary senescence in Mdm2 normal (Mdm2+) hepatocytes as described 
(Bird et al., 2018) (Fig. 4b). Based on these characteristics, cells can be readily distinguished by 
immunohistochemistry with 23% of primary and 10% of secondary senescence hepatocytes 
detected (Fig.S.4a). We have previously shown that both subpopulations of hepatocytes 
upregulate senescence markers (gH2AX, Il1A, SA-Beta Gal) and reduce BrdU incorporation (Bird 
et al., 2018). 
To establish if primary and secondary senescence can be distinguished based on the 
transcriptome in vivo, we performed scRNA-seq on hepatocytes using Smart-seq2 (Fig.4a). After 
filtering (Fig.S4b,c,Table S1), we retained 39 single cells from induced Mdm2 deleted mouse liver 
for downstream analysis. We distinguished Mdm2- cells from Mdm2+ hepatocytes by the absence 
of mapping reads over exon 5 and 6 of the Mdm2 gene (Fig.S.4d). We detected expression of 
Cdkn1a in both senescent populations consistently with the differences in CDKN1A protein levels 
detected by immunohistochemistry (Fig.4b), with lower (but not significant) Cdkn1a expression in 
Mdm2- compared to Mdm2+ hepatocytes (Fig.S.4e), enabling us to distinguish primary and 
secondary senescence. To verify a senescence phenotype in both Mdm2- and Mdm2+ 
hepatocyte populations, we conducted pathway analysis with upregulated pathways being 
enriched in p53 signalling, including CDKN1A, DNA damage response and cytokine signalling 
(Fig.S.4f).  We next asked if NIS plays a role in secondary senescence in vivo by analysing our 
single-cell data using three independent methods. Differential expressed genes between Mdm2+ 
and Mdm2- cells were identified using SCDE (Table S2) and genes were ranked between 
Mdm2+/Mdm2- cells for downstream analysis. Firstly, pathway analysis revealed enrichment in 
Notch signalling (Ratio of enrichment (RE) 7.07), Delta-Notch signalling (RE 4.63) and TGFB (RE 
4.11) signalling pathways (Fig.4c). Secondly, GSEA revealed Notch signalling pathway 
(NES=1.07) as one of the top 20 Kegg pathways enriched in Mdm2+/Mdm2- (Fig.4d) with leading 
edge genes Maml1 and Jag2 detectable mainly in Mdm2+ cells (Fisher’s exact test=6.93x10-7, 
Fig.4e). Housekeeping and hepatocyte-specific genes were expressed to the same level in the 
majority of cells regardless of Mdm2 status (Fig.4e). Thirdly, SCDE analysis confirmed the specific 
upregulation of Notch and TGFB targets Maml1 (aZ=0.4) and Rfng (aZ=0.39) with effector protein 
Smad3 (aZ=0.26) in Mdm2+ compared to Mdm2- hepatocytes (Fig.4f). To assess the proposed 
TGFB/CEBPB bias between primary and secondary senescence in vivo, we stained livers from 
uninduced and induced mice for CDKN1A and CEBPB by immunohistochemistry. Consistent with 
our in vitro data, we observed significantly higher CEBPB protein in primary (p<0.0001,Fig.4g) 
compared to secondary senescent hepatocytes. These lines of evidence show that secondary 
senescent hepatocytes are characterised by a NIS signature in vivo.  
Discussion 
Cancer heterogeneity is an expanding field of research, with little knowledge about cellular 
heterogeneity in a pre-cancerous state. Are all cells reacting similarly to oncogene activation or 
does an oncogenic insult result in a heterogeneous population? Understanding heterogeneity in 
a pre-cancerous state will inform distinct propensities for transformation in subpopulations. Our 
study uncovers heterogeneity in primary OIS and secondary senescence transcriptomes following 
an oncogenic insult using single-cell approaches. 
Paracrine induction of senescence is thought to be the main mediator of secondary senescence 
in OIS (Acosta et al., 2013; Kuilman et al., 2008). Our results challenge this canonical view 
implicating NIS as a synergistic driver of secondary senescence in vitro, in the most studied OIS 
background (RasV12) and in the liver in vivo. 
Primary and secondary senescent cells are not thought of as functionally distinct endpoints. We 
provide strong evidence for differences between primary OIS and Notch-mediated juxtacrine 
secondary senescence as they display distinct gene expression profiles and potentially different 
transformation potential (Acosta et al., 2013; Hoare et al., 2016). Some of our findings point to a 
functional diversification, for example, the blunted SASP response and the induction of fibrillar 
collagens in secondary senescence compared to OIS.  
We identified two transcriptional end-points for primary OIS, namely a Ras-driven and a NIS 
programme. Notch signalling is mediated through cell-to-cell contact (juxtacrine), and Hoare and 
colleagues have shown that it can be a transient state towards primary senescence induction 
(Hoare et al., 2016). Our data indicate cells carrying a composite transcriptional signature of 
paracrine and juxtacrine events as a facultative end-point for cells with detectable Ras activation 
(primary). The transformation potential of these heterogeneous populations needs addressing.   
Figure Legends 
Fig. 1. Secondary senescent cells only partially resemble paracrine induced senescence. 
a. Schematic representation of the time-course experiment. b. Number of senescent cells with 
reads mapping to the G>T mutation site of RAS gene. c. Monocle2 plot for time course 
experiment. The presence of the mutated RAS gene is indicated. Pie charts for the percentage of 
Ras+/Ras- cells in the top and bottom clusters. d. Box plots for the expression of senescence 
genes in the time-course experiment. The top and bottom bounds of the boxplot correspond to 
the 75 and 25th percentile, respectively. e. Unsupervised clustering using SC3 for senescent 
cells. Cells were annotated as either OIS (top senescence branch, purple), secondary 
senescence (bottom branch, green) or NA (neither, pink). f. Schematic representation of the co-
culture experiment. g. tSNE visualization of co-culture scRNA-seq. h. tSNE visualization of single 
cells grouped into 3 clusters. i. Box plots for the expression of senescence genes in the co-culture 
experiment. The top and bottom bounds of the boxplot correspond to the 75 and 25th percentile, 
respectively. j. Integration analysis of the two senescence clusters from time-course and co-
culture experiments. k. Overlap of differentially expressed (DE) genes between paracrine/OIS, 
time-course and co-culture experiments. Related to Fig.S.1,Table S1-4. 
Fig. 2. Secondary senescence comprises NIS signature in the majority of cells. a. Box 
plots for the expression of genes COL1A1, COL3A1 and COL5A2 in the time-course and co-
culture experiments (p-values<0.05). The top and bottom bounds of the boxplots correspond to 
the 75 and 25th percentile, respectively. b. Model suggesting NIS and RIS are regulated by 
Notch1 through TGFB and C/EBPB respectively. c. IPA analysis of the two senescence clusters 
from the time-course and co-culture experiments relative to growing. d. Box plots for the 
expression of TGFB1I1, CTGF and CEBPB genes in the time-course (top) and co-culture 
experiments (middle). The top and bottom bounds of the boxplot correspond to the 75 and 25th 
percentile, respectively. Bar graphs denoting expression of TGFB1 (n=6), TGFBL (n=6), and 
CEBPB (n=3) mRNA as measured by qPCR in OIS and GFP cells (bottom) (TGFB1: t = -3.2317, 
df = 5.5117, p= 0.02; TGFBI: t = -2.2567, df = 9.8141, p=0.05; CEBPB: t = 0.068192, df = 
3.2294, p=0.95, unpaired Student’s t-test. Error bars represent SEM). e. Representative image 
of GFP (secondary senescence) and CEBPB (red) immunofluorescence in the co-culture 
experiment. Mean intensity for primary (ER:Ras) and secondary senescent cells (GFP) was 
measured (p=0.016, unpaired Student’s t-test). Error bars are displayed as SEM. f. GSEA plots 
for the enrichment of secondary and primary OIS DE genes (time-course and co-culture 
experiments) in Hoare et al.’s NIS and RIS log2FC preranked genes. Normalised enrichment 
score (NES) and false discovery rate (FDR) are shown. g. Venn diagrams overlapping 
expression signatures from time-course (top panel) and co-culture (bottom panel) with NIS 
signature genes. (Secondary senescence: Secondary senescence/OIS upregulated genes; 
NIS: Hoare et al.’s NIS/RIS upregulated genes; RIS: Hoare et al.’s RIS/NIS upregulated genes). 
Related to Fig.S.2,Table S4. 
Fig. 3. NIS mediates secondary senescence in vitro. a. Schematic representation of co- 
cultures with perturbed Notch signalling. b. Bar plot for EdU incorporation in growing (black) or 
senescent (grey) EV or dnMAML1 cells co-cultured with ER:Ras as proportion of all cells scored. 
Error bars are displayed as SEM; F[7,16] = 20.63, p<0.001, one-way ANOVA with Tukey’s test. 
(n=3 per condition). Representative images are shown. c. Scmap cluster projection of the 
dnMAML1 and EV 10x scRNA-seq dataset to the GFP co-culture 10x scRNA-seq dataset (see 
Fig.1h). d. tSNE plot of single cells colored by the projection towards the GFP co-culture 10x 
dataset (see Fig.1h). Pie charts show percentage of cells. e. GSEA pre-ranked test for enrichment 
of Notch signaling in mVenus:EV identified as secondary senescence by scmap. f.Heatmap of 
single cell data comparing mVenus:EV and mVenus:dnMAML1 for collagens and SASP genes. 
Red=upregulated and blue=downregulated. g.GSEA pre-ranked test for enrichment of SASP 
genes in mVenus:dnMAML1 identified as secondary senescence by scmap. h. GSEA pre-ranked 
test for enrichment of E2F targets in mVenus:dnMAML1 identified as secondary senescence by 
scmap.i. Schematic representation of transwell co-culture assay of OIS and GFP cells. j. Heatmap 
of significantly differentially expressed genes (p<0.05) between GFP contact and GFP no contact 
cells. k. GSEA pre-ranked analysis for enrichment of Notch signaling in GFP contact cells 
compared to GFP no contact cells. l. Pathway analysis for DE genes between GFP contact/GFP 
no contact (p<0.05). m. GSEA pre-ranked analysis for enrichment of E2F targets in GFP no 
contact compared to GFP contact cells. Leading edge genes are indicated. Related to 
Fig.S.3,Table S2. 
Fig. 4. Notch signaling mediates secondary senescence in vivo a. Schematic 
representation of in vivo single-cell experiment. b. Representative immunofluorescence 
images of liver section from induced AhCre+Mdm2fl/fl and control AhCreWTMdm2fl/fl mice 
stained for p53 and CDKN1A. Intrinsically induced senescence (arrowhead) and secondary 
senescence (arrow) is indicated. Boxplot for CDKN1A intensity in primary versus secondary 
senescent cells. (senescence: F[1,50291] = 2766, p<0.0001; biological replicates: 
F[2,50291]=283.2, p<0.0001; senescence x biological replicates: F[2,50291]=280.5, p<0.0001, 
two-way ANOVA). Scale bar 22μm. c. Pathway analysis for Mdm2+ (secondary) genes. d. 
GSEA for Mdm2+/Mdm2- cells  (NES=1.07). Leading edge genes are indicated. e. Heatmap 
for Notch pathway, hepatocyte markers and Cdkn1a genes in Mdm2+ and Mdm2- cells. 
Constitutive genes and Cdkn1a were colored by their expression relative levels (binary: red 
expressed, white not expressed). f. SCDE for Maml1, Rfng and Smad3 in Mdm2+ cells 
(orange lines) and Mdm2- cells (blue lines). Joint posterior is marked by black line. Fold 
change of the genes in Mdm2+/Mdm2- is indicated in red and dotted lines mark the 95% 
confidence interval. MLE: Maximum likelihood estimation; CI: Confidence interval; Z: z-score. 
g. Representative immunofluorescence images of liver section from induced and control mice. 
Primary senescent cells (arrowheads) and secondary senescent cells (arrows) are indicated 
(CDKN1A: F[1,60145] =353.3, p<0.0001; biological replicates: F[2,60145]=1044, p<0.0001; 
CDKN1A x biological replicates: F[2,60145]=8.96, p<0.0001, two-way ANOVA). Scale bar 
22μm.Related to Fig.S.4,Table S1, 2. 
 
STAR Methods 
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Tamir Chandra (tamir.chandra@igmm.ed.ac.uk). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Animal models 
Animal welfare conditions have been previously described (Lu et al., 2015). All animal 
experiments were carried out on healthy, treatment naïve animals under procedural guidelines, 
severity protocols and within the UK with ethical permission from the Animal Welfare and Ethical 
Review Body (AWERB) and the Home Office (UK). AhCre+/WT Mdm2fl/fl and AhCreWT/WT 
Mdm2fl/fl mice (colony N4 C57/Bl6J background) were crossed. Male littermates were housed 
together, and when used in experiments were all >20g body weight and of 10-16 weeks age. 
Genotyping and single i.p. injection of β-Naphthoflavone (βNF, Sigma UK) at 20mg/kg were 
performed as previously described (Bird et al., 2018). 
 
Cell culture 
We used normal diploid human female lung fibroblasts IMR90 isolated at 16 weeks of gestation 
for all in vitro assays (ATCC® CCL-186™). pLNCX2-ER:rasG12V-expressing IMR90 (plasmid 
obtained from Addgene #67844) were maintained and senescence induced as described under 
5% O2 conditions (Young et al., 2009). ER:IMR90 cells were co-cultured with IMR90:GFP (pGIPZ-
GFP, a kind gift from M. Narita to J.C.A.) or an empty vector fused with mVenus (pLPC-puro-
mVenus, a kind gift from M. Narita to J.C.A.) or with a dominant negative form of MAML1 fused 
with mVenus (pLPC-puro-dnMAML1-mVenus, a kind gift from M. Narita to J.C.A.) cells at 10:1 
ratio. 
METHOD DETAILS 
Hepatocyte isolation 
Ex vivo primary hepatocytes were isolated using a modified retrograde perfusion technique as 
previously described (Lu et al., 2015). Hepatocytes were purified by pelleting through a 40% (v:v) 
percoll gradient prior to FACS sorting. 
Immunohistochemistry 
Mouse livers were harvested and partially stored in paraffin blocks following fixation in 10% 
formalin (in PBS) for 18 hours prior to embedding. Immunohistochemistry was performed as 
described (Bird et al., 2018). Three µm thick paraffin sections were double stained for 
p53/CDKN1A and CDKN1A/CEBPB using the CDKN1A clone HUGO291H (a gift from Serrano 
lab, CNIO in Madrid), and either C/EBPB clone 1H7 (Abcam) or p53 clone 1C12 (Cell Signalling). 
Detection was performed with TSA-Cy3 (Perkin Elmer, NEL744B001KT, 1:50) and TSA-FITC 
(Perkin Elmer, NEL741B001KT, 1:50). Images were captured on a Zeiss 710 Upright Confocal 
Z6008 microscope. Stained slides were scanned using the Opera Phoenix High Content 
screening system (Perkin Elmer) scanner and analysed using the Columbus software. 
Transwell assay 
ER:RasG12V-expressing cells were co-cultured with IMR90:GFP cells. The co-cultured cells were 
placed into the lower chamber of a transwell system (density 5x103 cells/well). Another pure 
population of IMR90:GFP cells were cultured in the upper chamber of the transwell system. All 
cells were maintained in 4-hydroxytamoxifen (Sigma) for 7 days. All experiments were performed 
in triplicate. 
Flow cytometry 
Flow cytometry was performed with three independent replicates as previously described 
(Kirschner et al., 2017) using 7-AAD (Biolegend), DAPI (Biolegend) and anti-Notch1-PE (R&D 
systems, FAB5317P, 1:20). Analysis was performed on the BD FACSAria II (BD Biosciences, 
San Jose, CA) using the BD CellQuest PRO software (BD Biosciences, San Jose, CA). Flow data 
were analysed with FlowJo v10 (Tree Star, Ashland, OR). 
RNA extraction 
RNA from three to four independent experiments was extracted using the RNeasy Mini Kit 
(Qiagen). All RNA passed with a RIN of 9 or above as determined by Bioanalyser profiling. 
Ribosome depletion was performed prior to bulk RNA sequencing. 
qPCR 
cDNA was generated as previously described using the Tetro cDNA synthesis kit (Bioline) 
(Kirschner et al., 2015). qPCR was performed on a LightCycler 480 (Roche) using Sybr Green 
method as previously described (Kirschner et al., 2015). Primer sequences are in Supp. Table 3. 
EdU incorporation and SA-Beta Gal staining 
EdU incorporation and SA-Beta gal staining was performed as previously described (Kirschner et 
al., 2015). EdU incorporation was detected using the Click-iT™ EdU Alexa Fluor 555 imaging kit 
(ThermoScientific). For stable cell cycle arrest, cells were co-cultured for two weeks, separated 
by FACS according to GFP status and cultured as OIS and GFP cells for another week before 
pulsing them with EdU for 24 hours. 
Immunofluorescence 
Immunoflurorescence was performed as previously described (Kirschner et al., 2015). Anti- 
C/EBPB clone E299 (Abcam) was used as 1:500 dilution. 
Confocal microscopy and Image analysis 
BriteMac confocal microscope was used to visualize cells at 40x. Images were analysed using 
ImageJ. Percentages of SAHF, YFP/GFP and EdU-positive cells were calculated by assessing 
1600-2000 cells  per experiment from three independent experiments. 
Single cell data generation 
Smart-Seq2 was performed on sorted ER:IMR90 cells or hepatocytes as previously described 
(Kirschner et al., 2017). Single cell data for all co-culture experiments were generated using the 
Chromium Single Cell 3' Chip Kit v2 (10xGenomics), following the manufacturer’s instructions. 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Bioinformatics analysis 
Sequencing reads processing, alignment and quantification of time-course experiment 
Smart-Seq2 generated paired-end reads were quality trimmed using Trim galore 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) and aligned to the human 
reference genome, hg19, neomycin sequence from pLNCX2-ER-ras_neo, ERCC spike-in 
sequences and RasV12 using HISAT v2.0.1beta (Kim et al., 2015). Cells with less than 200,000 
hg19 aligned reads, and a ratio of ERCC RNA spike-in control aligned reads to total aligned reads 
greater than 0.5 were omitted. hg19 aligned reads were randomly downsampled to 200,000 
reads. Genes were quantified using HTSeq-0.6.1 (Anders et al., 2015). Cells with more than 
80,000 total gene counts and at least 500 genes with at least one count were used for downstream 
analysis. 224 IMR90 cells (100 Growing cells, 41 Day 2 cells, 42 Day 4 cells and 41 senescent 
cells) passed this second filtering step and used for downstream analyses. 
Sequencing reads processing, alignment, quantification and analysis of 10x Chromium 
RNA-seq data 
Cell Ranger 2.0.1 (10x Genomics) was used to align the GFP and ER:RasG12V co-culture 10x 
Chromium RNA-seq reads to hg19, TurboGFP, puromycin sequence from pGIPZ and neomycin 
sequence from pLNCX2-ER-ras_neo, and to generate gene-cell matrices. The growing and 
senescence dataset were aggregated using “cellranger aggr”. The data were subsequently 
processed using Seurat 2.3.0 with cells with less than 15% mitochondrial reads and at least 2500 
number of genes being retained (Butler et al., 2018). Seurat 2.3.0 with the default parameters 
(unless otherwise stated) was used to generate the t-SNE plots (resolution:0.4; dimensions used: 
1:15) and three clusters were identified using sparcl 1.0.3 (https://cran.r-
project.org/web/packages/sparcl/index.html). SCDE v1.99.1 was used to identify differentially 
expressed genes between OIS cluster and secondary senescent cluster (Kharchenko et al., 
2014). The DE genes (p-values < 0.05) (Supp. Table 2) were used as the defined gene sets for 
GSEA Preranked analysis of NIS and RIS log2FC ranked genes. GFP+ cells were identified as 
cells with > 0.3 normalized expression of GFP or puromycin and Ras+ cells were identified as 
cells with non-zero expression of neomycin or  one or more reads supporting the G>T mutation 
at Chr11:534288 as identified by FreeBayes v0.9.20-8-gfef284a (Garrison and Marth, 2012). 
Integration analysis between Smart-seq2 time-point data and 10x data were performed using the 
canonical correlation analysis in Seurat 2.3.0, in which the union of the top 50 highest dispersion 
genes and the first two dimensions were used. 
Cell Ranger 2.0.1 (10x Genomics) was used to align the 10x Chromium RNA-seq reads from 
mVenus:dnMAML1 or mVenus:EV co-cultured with  ER:RasG12V cells to hg19, mVenus sequence, 
puromycin sequence from pLPC-puro and neomycin sequence from pLNCX2-ER-ras_neo to 
generate gene-cell matrices. mVenus cells were identified as cells with more than zero normalized 
expression of mVenus or puromycin and Ras+ cells were identified as cells with non-zero 
expression of neomycin or  one or more reads supporting the G>T mutation at Chr11:534288 as 
identified by FreeBayes v0.9.20-8-gfef284a (Garrison and Marth, 2012). The data were 
subsequently processed using Seurat 2.3.0 with cells with less than 10% mitochondrial reads and 
at least 2500 genes being retained. Seurat 2.3.0 with the default parameters (unless otherwise 
stated) was used to generate the tSNE plots (resolution:0.6; dimensions used: 1:7). The cells 
were projected to the 10x Chromium GFP and ER:RasG12V co-culture dataset using scmap-cluster 
v1.4.1. 
Sequencing reads processing, alignment and quantification of in vivo data 
Smart-Seq2 generated paired-end reads were quality trimmed using Trim galore 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) and aligned to the mouse 
reference genome mm10 and ERCC spike-in sequences using HISAT v2.0.1beta (Kim et al., 
2015). The mm10 aligned reads were randomly downsampled to 50,000 reads. Cells with less 
than 50,000 reads, less than 20,000 gene count, less than 500 genes with at least one read 
detected and with the log-transformed number of expressed genes and library size of 3 median 
absolute deviation below the median value were removed (Lun et al., 2016). 39 single cells from 
the induced hepatocytes and 19 cells from the uninduced hepatocytes passed these filters. 22 
primary senescent cells were identified from the induced hepatocytes as cells with no reads 
mapping over exon 5 and 6 (chr10:117695953-117696049, chr10:117696381-117696439, 
chr10:117701565-117701614 and chr10:117702202-117702335) of Mdm2 gene before the 
downsampling. 17 cells were classified as secondary hepatocytes as judged by their gene 
expression profiles. Differential genes expression between Mdm2+ cells and Mdm2- cells was 
identified using SCDE v1.99 and log2FC ranked gene list from SCDE was used in GSEA pre-
ranked analysis. Genes with more than zero log-transformed normalized count (McCarthy et al., 
2017) were labeled red, and otherwise white in the binary heatmap. Pathway enrichment was 
identified using WebGestalt (Wang et al., 2017) with genes that have a z-score of greater than 2 
in Mdm2+ cells /Mdm2- comparison. 
Differential gene expression analysis and temporal ordering of cells 
We used raw counts from HTSeq-0.6.1 (Anders et al., 2015) as an input to single-cell differential 
expression (SCDE v1.99.1) (Kharchenko et al., 2014) for differential gene expression analysis 
between growing and senescence. Cut-off for significantly differentially expressed (DE) was set 
at 0.05. The expression magnitude (fragments per million) was obtained from SCDE and 
converted to FPKM as an input for Monocle2 (Qiu et al., 2017). Monocle2 was used to order the 
transitions of senescent cells of different time points at a pseudo-temporal resolution, and single-
cell data were reduced to a 2-dimensional space by using the DDRTree algorithm implemented 
in Monocle2 (Qiu et al., 2017). Specifically, DE genes between senescence and growing 
conditions that were identified in SCDE were used to define the trajectory. A consensus clustering 
approach, SC3, was also applied to the raw count of single cells and used to cluster senescent 
cells (Kiselev et al., 2017). 
Detection of RasV12 construct in Smart-seq2 dataset 
We counted reads with a G>T mutation at Chr11:534288 using samtools v1.2 mpileup and 
bcftools v1.2 (Li, 2011). Cells with more than 1 read supporting over G>T mutation or at least 9 
reads mapping to the neomycin sequence are considered as RasV12 positive cells. 
Paracrine-induced senescence and RIS microarray data analysis 
Log2 RMA signal intensity of RIS IMR90 cells and IMR90 co-cultured in transwells with RIS cells 
were obtained from GEO GSE41318. Differentially expressed genes were identified using limma 
(Ritchie et al., 2015) and an adjusted p-value of 0.05 was used as the cut-off for significant genes. 
Notch and Ras-induced senescence data and GSEA analysis 
We used NIS and RIS RNA-seq data with accession number GSE72404. Reads were aligned to 
as described above. Differential gene expression analysis between NIS and RIS was performed 
using DESeq2 (Love et al., 2014). The log2 fold change for each gene was used to rank the list 
of genes in GSEA Preranked analysis (Subramanian et al., 2005). Differentially expressed (DE) 
genes between senescence top and bottom were identified using SCDE with a p-value cutoff of 
0.05. The DE genes defined the gene set in GSEA Preranked analysis. 
Sequencing reads alignment and quantification of transwell bulk RNA-sequencing data 
Reads were aligned to the human reference genome hg19 using HISAT v2.0.1beta (Kim et al., 
2015) and those that mapped to annotated genes were quantified using HTSeq-0.6.1 (Anders et 
al., 2015). Differential gene expression was determined using DESeq2 v1.22.1 (Love et al., 2014). 
Over-representation analysis was performed using WebGestalt (Wang et al., 2017) and GSEA 
pre-ranked analysis was performed using the ranking of genes based on the log2FC between 
GFP contact and GFP no contact. 
Statistical analysis 
All t-tests and one-way ANOVA for the in vitro data were performed in R. TukeyHSD was used 
as the post hoc test for one-way ANOVA. For the in vitro data, each experiment and measurement 
were obtained from three independent experiments unless otherwise specified in the figure 
legends. Barplots are represented as means with SEM. Statistical significance was set at p < 0.05. 
T-test for the in vivo data was performed in R and the two-way ANOVA followed by Tukey’s test 
for the in vivo data was performed using GraphPad Prism. All animal data were obtained from 
three biological replicates. Details of all statistical analysis can be found in associated figure 
legends. For qPCR analysis, Delta delta Ct method was used for quantification with error bars 
resulting from the delta Ct expression of three to four biological replicates. A two-sided t-test was 
used to calculate p-values. 
DATA AND SOFTWARE AVAILABILITY 
All scRNA-seq and bulk RNA-seq experiments are accessible through GEO accession number 
GSE115301. All imaging data are available as Mendeley data set under doi: 
10.17632/y76pb7s8h3.1. 
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Supplemental Text and Figures
Figure S1, Related to Figure 1.  
(A,B) Filtering according to total mapped reads. Cells with less than 200,000 human aligned 
reads and with a ratio of ERCC RNA spike-in control aligned reads to total aligned reads that 
is greater than 0.5 were removed.  
(C) The second filtering step was performed to retain cells that have greater than 80,000 total 
gene counts and at least 500 genes with at least one count. Cell were normalised by 
downsampling to 200,000 aligned reads for downstream analysis. 
(D) The number of cells that passed the filtering step in (A) and (B) 
(E) BrdU, SAHF and SA-Beta galactosidase counts in ER:Ras fibroblasts. Days indicated time 
of tamoxifen treatment. Error bars are SEM, n=3 for each time point. F[3,8] = 234.8, p<0.001; 
**p < 0.001 using one-way ANOVA with Tukey’s test. Scale bar 100μm.  
(F) Number of reads aligning to the neomycin sequence from the pLNCX2-ER-ras_neo 
construct in senescent single cells in the time-course experiment.  
(G) Fraction of cells that are RasV12+ in each condition in the time-course experiment.  
(H) IPA analysis of OIS/growing in time-course scRNA-seq.  
(I) Silhouette plot to assess the quality of clustering. The average silhouette width was 0.47.  
(J) Box plots for gene expression of CDKN2B (n=3), IL6 (n=3), and IL8 (n=3) mRNA measured 
by qPCR in OIS and GFP cells. Unpaired Student’s t-test showed no significant difference in 
senescent markers expression between OIS and GFP cells. Error bars represent SEM.  
(K) SA-Beta galactosidase counts in OIS and GFP cell s. (OIS t = 10.199, df = 2.0096, p= 
0.009; GFP t = 15.239, df = 2.3673, p= 0.002 using unpaired Student’s t-test). Scale bar 
100μm.  
(L) Bar plots showing EdU incorporation in GFP cells co-cultured with ER:Ras cells after 21 
days as proportion of all cells scored. Error bars are displayed as SEM; **p<0.001, *p<0.05. 
Representative images are shown. Scale bar 20μm. (ER:Ras t = -9.899, df = 2.86 68, p= 
0.0024; GFP t = 10.395, df = 3.3348, p= 0.0012 using unpaired Student’s t-test) (n=3 per 
experiment). 
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Figure S2, Related to Figure 2 
(A) IPA analysis of the two senescence clusters from time-course and co-culture scRNA-seq. 
Red indicates activated upstream regulator and blue indicates inhibited upstream regulator.  
(B) GSEA was used to assess the enrichment of secondary and primary senescence (OIS) DE 
genes in Hoare et al.’s NIS and RIS log2FC preranked genes. NES and FDR are shown.  
(C) Venn diagrams overlapping expression signatures from top panel: time-course and bottom 
panel: co-culture experiments with NIS signature genes (OIS: OIS/Secondary senescence 
upregulated genes; NIS: Hoare et al.’s NIS/RIS upregulated genes; RIS: Hoare et al.’s RIS/NIS 
upregulated genes) 
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Figure S3, Related to Figure 3  
(A) Bar plot showing the expression of CTGF (n=6) and COL3A1 (n=3) genes in EV or dnMAML1 
cells compared to ER:Ras senescent cells by qPCR. (COL3A1: t=5.3405, df=2.4861, p=0.02; 
CTGF: t=2.2104, df=8.4894, p=0.056 using unpaired Student’s t- test). Error bars represent 
SEM.  
(B) Bar plot denoting the proportion of growing (black) or senescent (grey) mVenus cells with 
dnMAML1 or EV as proportion of all cells scored. Error bars are displayed as SEM; F[3,8] = 
10.05, p<0.05 using one-way ANOVA with Tukey’s test (n=3 for each condition). Representative 
images of mVenus cells and cells stained with DAPI are shown on the right. Scale bar 10μm.  
(C) SAHF counts in OIS and secondary senescent (unpaired Student’s t-test, ER:Ras t=-34.05, 
df=2.12, ** p<0.01; mVenus:EV t=-1.23, df=2.28, p=0.32; n=3 for each condition). 
Representative images are shown on the right.  
(D) GSEA pre-ranked test for enrichment of interferon gamma response in mVenus:dnMAML1 
identified as secondary senescence by scmap.  
(E) GSEA pre-ranked test for enrichment of TGF-beta signalling in GFP contact compared to GFP 
no contact cells. mVenus:dnMAML1 identified as secondary senescence by scmap.  
(F) GSEA pre-ranked test for enrichment of mVenus:EV signature genes in GFP contact/GFP 
no contact upregulated gene set.  
(G) Schematic representation of co- culturing mVenus cells with Day 3 or Day 7 OIS cells.  
(H) Bar plot showing EdU incorporation in OIS or mVenus:EV cells in growing (black), co- culture 
with Day 3 OIS (grey) or Day 7 OIS cells (blue). Error bars are displayed as SEM; F[5,18] = 
144.4, p<0.001 using one-way ANOVA with Tukey’s test (n=3 for each except for Day 3 OIS 
(n=6)). Representative images are shown below the bar plot. Scale bar 10μm.  
(I) Bar plot showing EdU incorporation in OIS or mVenus:dnMAML1 cells in growing (black), co- 
culture with Day 3 OIS (grey) or Day 7 OIS cells (blue). Error bars are displayed as SEM. F[5,24] 
= 58, p<0.001 using one-way ANOVA  with   Tukey’s   test   (n=3   for all conditions except for 
Day3 OIS (n=6)). **p<0.001, *p<0.05. Representative images are shown on the right of the bar 
plot. Scale bar 10μm. j. Barplot showing the upregulation of NOTCH1 on the cell surface of 
mVenus:EV and mVenus:dnMAML1 cells 4 days after co-culture with ER:Ras compared to non-
co-cultured, growing mVenus:EV (mVenus:EV t = -3.27, df = 2.01, p-value = 0.041; 
mVenus:dnMAML1 t = -3.29, df =3.03,  p-value = 0.023 using one-sided t- test). Error bars 
represent SEM. Representative FACs plots showing NOTCH1 staining of YFP uninduced 
fibroblasts and YFP:EV and YFP:dnMaml1 at 4 days of co-culture. 
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Figure S4, Related to Figure 4 
(A) Bar graph denoting the percentage of primary and secondary hepatocytes (Primary: 
t=2.4241, df=2.0641, p-value = 0.1324; Secondary: t=7.7563, df=2.0053, p=0.0161 using 
unpaired Student’s t-test).  
(B) Histogram with the number of induced and control cells is plotted against log mapped reads. 
75 single cells with at least 50,000 aligned reads are downsampled to 50,000 reads.  
(C) Dot plot with the number of genes with at least one read to total gene count for induced 
(black) and control (grey) cells. Cells with a total gene count of more than 20,000 and 500 genes 
detected were retained.  
(D) 17 Mdm2- cells were identified as cells with no reads mapping to exon5/6 of Mdm2 gene 
and 22 Mdm2+ cells contained reads mapping to the exons.  
(E) Box plots showing the expression of Cdkn1a in induced cells relative to control (p=4.46x10-
18). The top and bottom bounds of the boxplot correspond to the 75 and 25th percentile, 
respectively.  
(F) Pathway analysis for induced/uninduced hepatocytes. Kegg pathways are shown in 
turquoise and Wikipathways in blue. 
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